March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Inflammatory Role of ProNGF/p75NTR in Müller cells of the Diabetic Retina
Author Affiliations & Notes
  • Barbara A. Mysona
    UGA Clinical Pharmacy program, University of Georgia, Augusta, Georgia
  • Mohammed A. Abdelsaid
    UGA Clinical Pharmacy program, University of Georgia, Augusta, Georgia
  • Su Matragoon
    UGA Clinical Pharmacy program, University of Georgia, Augusta, Georgia
  • Bindu Pillai
    UGA Clinical Pharmacy program, University of Georgia, Augusta, Georgia
  • Azza El-Remessy
    UGA Clinical Pharmacy program, University of Georgia, Augusta, Georgia
  • Footnotes
    Commercial Relationships  Barbara A. Mysona, None; Mohammed A. Abdelsaid, None; Su Matragoon, None; Bindu Pillai, None; Azza El-Remessy, None
  • Footnotes
    Support  JDRF 2008-149
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2003. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Barbara A. Mysona, Mohammed A. Abdelsaid, Su Matragoon, Bindu Pillai, Azza El-Remessy; Inflammatory Role of ProNGF/p75NTR in Müller cells of the Diabetic Retina. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2003.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Diabetic retinopathy, the leading cause of blindness in U.S. working age adults, is characterized by neurodegeneration, inflammation, and vascular dysfunction. Our recent studies using diabetic animals show that neurodegeneration and vascular leakage are associated with an imbalance of nerve growth factor (NGF) leading to accumulation of its precursor (proNGF) and its receptor, p75NTR. Here, we examine the role of proNGF/p75NTR in mediating retinal inflammation and vascular dysfunction in the diabetic retina.

Methods: : STZ-diabetes was induced in wild type and p75NTR knockout (KO) mice. After 4 weeks, vascular permeability was assayed by extravasation of BSA-conjugated fluorescein. Müller cells were cultured for 2 days in high glucose (25 mM), normal glucose (5 mM), or osmolar controls and stimulated with cleavage-resistant proNGF in the presence or absence of compound E (an inhibitor of p75NTR intracellular domain cleavage) and epicatechin (a nitration inhibitor that reduces p75NTR expression). Expression of p75NTR, NGF, proNGF, and inflammatory mediators were determined in retinal and cell lysates by Western-Blot. Animals used for this research were handled in accord with ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Results: : Deletion of p75NTR prevented diabetes-induced vascular permeability detected in wild-type mice. In diabetic wild-type mice NGF protein levels decreased by 50% while NFkB and TNF-α levels increased by 1.8 fold and 6 fold, respectively (N=5-7, P < 0.01). These changes were not observed in diabetic p75NTR KO mice. Interestingly, basal levels of NGF, NFkB, and TNF-α were altered in p75NTR KO mice (N=5-7, P < 0.05). Müller cell studies showed that addition of exogenous, cleavage-resistant proNGF enhanced high glucose induced elevation of p75NTR. Elevation of NFkB and TNF-α observed in high glucose, cleavage-resistant proNGF treated cells was reduced by co-treatment with compound E and epicatechin (N = 4-6, P < 0.05).

Conclusions: : Deletion of p75NTR or inhibition of its cleavage reduced the diabetes induced elevation of inflammatory mediators that cause increased vascular permeability. Inhibition of the proNGF/p75NTR inflammatory axis is a potential therapeutic target in the diabetic retina.

Keywords: diabetic retinopathy • inflammation • Muller cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×